沙特阿拉伯王国政府所属的官方政府网站。
周四 25 6月 2026
沙特官方政府网站的域名以下列后缀结尾 gov.sa
沙特阿拉伯王国所有政府机构的官方网站均以 .gov.sa 结尾。
政府网站使用以下协议。 HTTPS 用于加密和安全。
沙特阿拉伯王国所有政府机构的官方网站均以 .gov.sa 结尾。
| المنتج | التاريخ | معلومات السلامة | المرفقات |
|---|---|---|---|
| FEGONA (Fingolimod) | FEGONA (Fingolimod): Risk related to the effects of FEGONA on the immune system. |
||
| Fingolimod (Gilenya®) | Risks related to the effects on the immune system . |
||
| Xarelto ® (Rivaroxaban) | Warnings and precautions for use to reduce the risk of bleeding. |
||
| Motilium® (Domperidone) | New recommendations to minimise the cardiac risks . |
||
| Amistop® (Domperidone) | New recommendations to minimise the cardiac risks . |
||
| Mododom® (Domperidone) | New recommendations to minimise the cardiac risks . |
||
| Prokinin® (Domperidone) | New recommendations to minimise the cardiac risks . |
||
| Arzerra® (ofatumumab) | Safety update on a fatal infusion reaction reported in a patient with Chronic lymphocytic leukemia (CLL) who was treated with intravenous ofatumumab . |
||
| Arzerra® (ofatumumab) | change to safety information regarding update to hepatitis B virus reactivation warning . |
||
| Riacavilol® (Carvedilol) | Important safety update of prescribing information for Carvidol® (Carvedilol) |
评论与建议
如对政府服务有任何咨询或意见,请填写所需信息。